Date of 2026 Annual General Meeting
other announcement
Latest articles and price-sensitive announcements with AI sentiment classification.
other announcement
director_dealing announcement
other announcement

Vectus is the first anti-fibrotic company to be targeting not just slowing progression but actually reversing idiopathic pulmonary fibrosis. ... Read More The post Dr Boreham’s Crucible: Vectus Biosystems in good company on the orphan route appeared first on Stockhead.
On 29 July 2026, Vectus Biosystems Limited (ASX: VBS) issued 176,703 fully paid ordinary shares following option exercises under its Employee Incentive Plan, with CEO and CTO Dr Tara Speranza receiving the majority of these shares. Key Points Vectus Biosystems Limited (ASX: VBS) issued 176,703 fully paid ordinary shares on 29 July 2026 Dr Tara Speranza, CEO and CTO, acquired 163,500 shares through option exercise under the Employee Incentive Plan A Vectus contractor received 13,203 shares fol...
other announcement
Vectus Biosystems Ltd (ASX: VBS) Shares Rise as One-Year Gains Reach 372.97% Kalkine
other announcement
What's Driving Vectus Biosystems' (ASX: VBS) Share Price? Kalkine
Why Is Vectus Biosystems (ASX:VBS) on Investors' Radar Despite Today's Pullback? Kalkine
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement